- Details
- Description
-
Packaging Size100c/Bottle
-
Strength0.5mg
-
CompositonAnagrelide
-
TreatmentThrombocythemia,Polycythemia Vera
-
FormCapsule
-
BrandLuciAnagre
-
Quantity Unit0.5mg*100c/Box
-
ManufacturerLucius Pharmaceuticals (Lao) Co.,Ltd
About Anagrelide
Anagrelide is a drug used for the treatment of essential thrombocytosis (also known as essential thrombocythemia), or overproduction of blood platelets. It also has been used in the treatment of chronic myeloid leukemia.
Thrombocythemia
Indicated for essential thrombocythemia and for thrombocythemia secondary to myeloproliferative disorders to decrease risk thrombosis and thrombo-hemorrhagic event
0.5 PO q6hr or 1 mg q12hr; increase PRN not more frequently than 0.5 mg/day/week
Not to exceed 10 mg/day or 2.5 mg/dose
Platelet count responds typically in 7-14 days; time to complete response is 4 to 12 weeks